The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/european League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study
Open Access
- 28 December 2007
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (1), 4-13
- https://doi.org/10.1002/art.23248
Abstract
Objective To validate a core set of outcome measures for the evaluation of response to treatment in patients with juvenile dermatomyositis (DM). Methods In 2001, a preliminary consensus‐derived core set for evaluating response to therapy in juvenile DM was established. In the present study, the core set was validated through an evidence‐based, large‐scale data collection that led to the enrollment of 294 patients from 36 countries. Consecutive patients with active disease were assessed at baseline and after 6 months. The validation procedures included assessment of feasibility, responsiveness, discriminant and construct ability, concordance in the evaluation of response to therapy between physicians and parents, redundancy, internal consistency, and ability to predict a therapeutic response. Results The following clinical measures were found to be feasible, and to have good construct validity, discriminative ability, and internal consistency; furthermore, they were not redundant, proved responsive to clinically important changes in disease activity, and were associated strongly with treatment outcome and thus were included in the final core set: 1) physician's global assessment of disease activity, 2) muscle strength, 3) global disease activity measure, 4) parent's global assessment of patient's well‐being, 5) functional ability, and 6) health‐related quality of life. Conclusion The members of the Paediatric Rheumatology International Trials Organisation, with the endorsement of the American College of Rheumatology and the European League Against Rheumatism, propose a core set of criteria for the evaluation of response to therapy that is scientifically and clinically relevant and statistically validated. The core set will help standardize the conduct and reporting of clinical trials and assist practitioners in deciding whether a child with juvenile DM has responded adequately to therapy.Keywords
This publication has 35 references indexed in Scilit:
- Normal scores for nine maneuvers of the Childhood Myositis Assessment ScaleArthritis Care & Research, 2004
- Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessmentsArthritis & Rheumatism, 1997
- Preliminary definition of improvement in juvenile arthritisArthritis & Rheumatism, 1997
- Measurement of health status in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1994
- Serial magnetic resonance imaging in juvenile dermatomyositisArthritis & Rheumatism, 1991
- Comparisons of Five Health Status Instruments for Orthopedic EvaluationMedical Care, 1990
- Comparative measurement efficiency and sensitivity of five health status instruments for arthritis researchArthritis & Rheumatism, 1985
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960
- Coefficient alpha and the internal structure of testsPsychometrika, 1951